
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors Inc. has experienced a positive outlook, reflected by an increase in normalized Funds From Operations (NFFO) estimates for 2025, now projected at $4.80 per share, which aligns with management's guidance range. A similar upward adjustment has been made for the 2026 FFO estimate, which now stands at $5.03 per share, slightly exceeding the $5.00 consensus. The company's solid performance and encouraging outlook from management, particularly following a strong second quarter, reinforce optimism regarding its revenue generation capabilities and market position within the senior housing sector.
Bears say
National Health Investors Inc. is projected to experience lower earnings growth over the upcoming years, primarily due to challenges that may arise from operator transitions and issues that hinder profitability. The performance of the company's stock may be negatively impacted if the NHC rent reset falls short of investor expectations or if deferred rent collections weaken. Additionally, potential risks include operational difficulties faced by its operators, particularly in the context of health crises such as another pandemic, which could further strain revenue generation.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares